This week, read about promising pipeline treatments, sebaceous gland destruction, and opinions on antibiotic and isotretinoin use in acne patients Read about more topics here.
 
 
Pipeline treatments show promise for acne patients
Hilary E. Baldwin, M.D. discusses advances in acne treatment that have expanded treatment options, allowing physicians to improve outcomes in patients with moderate-to-severe acne.
 
ADVERTISEMENT
Sebaceous gland destruction a viable strategy to treat acne
Speaking about device-based acne treatments at Maui Derm for Dermatologists 2020 meeting, Fernanda Sakamoto, Ph.D., M.D., discussed PDT and other approaches for targeting the sebaceous gland.
 
An update on antibiotic use for acne
Read insights from James Q. Del Rosso, D.O., as he discusses antibiotic resistance, isotretinoin relapse, and laboratory monitoring for patients on isotretinoin and spironolactone.
 
Expert offer insight on isotretinoin use
James J. Leyden, M.D., has four decades of experience prescribing isotretinoin for the treatment of severe acne both in clinical practice and clinical research. Read his conclusions about dosing and use of the oral retinoid in this article.
 

Connect with us on Twitter and Facebook for daily updates.
 
ADVERTISEMENT
Atopic dermatitis: identifying causes of inflammation
Why is it so difficult to pinpoint reasons for inflammation in patients who develop atopic dermatitis? In this Dermatology Times®podcast, Peter Lio, MD, provides in-depth analyses of both the "immune dysfunction" hypothesis and the "barrier defect" hypothesis. Listen to the podcast now.
 
 
From our Latest Issue
 
Dermatology Times cover
Experts advise caution over early, emerging treatments
 
 
New ways to tackle itch in atopic dermatitis
 
A paradigm shift in squamous cell carcinoma treatment